Purchase Order 75N93023P01069
Award Date
8/10/23
Potential Completion Date
2/29/24
Potential Value
$16K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...
Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company, for plasmid cloning and propagation services. The $11,409.96 contract is for work to be performed in Piscataway, New Jersey. Genscript, which specializes in gene synthesis, gene editing, and other molecular biology services, has received numerous prime and...
This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for $19,614.63 to provide "GENOMIC EDITING SERVICE KNOCK-OUT" services to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. Genscript, which is not a small business, has received...
This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...
This federal contract award to Genscript USA Inc. is for $182,897.61 to provide custom gene synthesis services to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is a firm fixed-price purchase order with no set-aside designation, and the services include DNA synthesis, subcloning, and plasmid preparation to support HIV research being conducted at the NIH...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...